184 related articles for article (PubMed ID: 27067323)
21. Transcriptional profiling of a mice plague model: insights into interaction between Yersinia pestis and its host.
Liu H; Wang H; Qiu J; Wang X; Guo Z; Qiu Y; Zhou D; Han Y; Du Z; Li C; Song Y; Yang R
J Basic Microbiol; 2009 Feb; 49(1):92-9. PubMed ID: 18759226
[TBL] [Abstract][Full Text] [Related]
22. Comparison of 2 antibiotics that inhibit protein synthesis for the treatment of infection with Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague.
Heine HS; Louie A; Sorgel F; Bassett J; Miller L; Sullivan LJ; Kinzig-Schippers M; Drusano GL
J Infect Dis; 2007 Sep; 196(5):782-7. PubMed ID: 17674322
[TBL] [Abstract][Full Text] [Related]
23. Bacterial filamentation of Yersinia pestis by beta-lactam antibiotics in experimentally infected mice.
Davis KJ; Vogel P; Fritz DL; Steele KE; Pitt ML; Welkos SL; Friedlander AM; Byrne WR
Arch Pathol Lab Med; 1997 Aug; 121(8):865-8. PubMed ID: 9278616
[TBL] [Abstract][Full Text] [Related]
24. Pathology and Pathogenesis of Yersinia pestis.
Du Z; Wang X
Adv Exp Med Biol; 2016; 918():193-222. PubMed ID: 27722864
[TBL] [Abstract][Full Text] [Related]
25. High-throughput screening of a collection of known pharmacologically active small compounds for inhibitors of Salmonella invasion and intracellular replication.
Ridge Y; Landini P; Thompson A
J Appl Microbiol; 2018 Sep; 125(3):724-730. PubMed ID: 29693760
[TBL] [Abstract][Full Text] [Related]
26. Screening of an FDA-Approved Library for Novel Drugs against
Gur D; Chitlaru T; Mamroud E; Zauberman A
Antibiotics (Basel); 2021 Jan; 10(1):. PubMed ID: 33401634
[No Abstract] [Full Text] [Related]
27. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
[TBL] [Abstract][Full Text] [Related]
28. Enrichment of Yersinia pestis from blood cultures enables rapid antimicrobial susceptibility determination by flow cytometry.
Steinberger-Levy I; Zahavy E; Cohen S; Flashner Y; Mamroud E; Aftalion M; Gur D; Ber R
Adv Exp Med Biol; 2007; 603():339-50. PubMed ID: 17966430
[TBL] [Abstract][Full Text] [Related]
29. Assessment of a fluoroquinolone, three beta-lactams, two aminoglycosides, and a cycline in treatment of murine Yersinia pestis infection.
Bonacorsi SP; Scavizzi MR; Guiyoule A; Amouroux JH; Carniel E
Antimicrob Agents Chemother; 1994 Mar; 38(3):481-6. PubMed ID: 8203841
[TBL] [Abstract][Full Text] [Related]
30. Mice naturally resistant to Yersinia pestis Delta pgm strains commonly used in pathogenicity studies.
Congleton YH; Wulff CR; Kerschen EJ; Straley SC
Infect Immun; 2006 Nov; 74(11):6501-4. PubMed ID: 16954401
[TBL] [Abstract][Full Text] [Related]
31. Integrating high-content imaging and chemical genetics to probe host cellular pathways critical for Yersinia pestis infection.
Kota KP; Eaton B; Lane D; Ulrich M; Ulrich R; Peyser BD; Robinson CG; Jaissle JG; Pegoraro G; Bavari S; Panchal RG
PLoS One; 2013; 8(1):e55167. PubMed ID: 23383093
[TBL] [Abstract][Full Text] [Related]
32. The weak interaction of LcrV and TLR2 does not contribute to the virulence of Yersinia pestis.
Reithmeier-Rost D; Hill J; Elvin SJ; Williamson D; Dittmann S; Schmid A; Wilharm G; Sing A
Microbes Infect; 2007 Jul; 9(8):997-1002. PubMed ID: 17556003
[TBL] [Abstract][Full Text] [Related]
33. [Yersinia pestis and plague - an update].
Stock I
Med Monatsschr Pharm; 2014 Dec; 37(12):441-8; quiz 449. PubMed ID: 25643450
[TBL] [Abstract][Full Text] [Related]
34. Yersinia pestis YopJ suppresses tumor necrosis factor alpha induction and contributes to apoptosis of immune cells in the lymph node but is not required for virulence in a rat model of bubonic plague.
Lemaître N; Sebbane F; Long D; Hinnebusch BJ
Infect Immun; 2006 Sep; 74(9):5126-31. PubMed ID: 16926404
[TBL] [Abstract][Full Text] [Related]
35. Effect of fat in ground beef on the growth and virulence plasmid (pYV) stability in Yersinia pestis.
Bhaduri S
Int J Food Microbiol; 2010 Jan; 136(3):372-5. PubMed ID: 19875186
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of ciprofloxacin-gentamicin combination therapy in murine bubonic plague.
Lemaître N; Ricard I; Pradel E; Foligné B; Courcol R; Simonet M; Sebbane F
PLoS One; 2012; 7(12):e52503. PubMed ID: 23285069
[TBL] [Abstract][Full Text] [Related]
37. A macrophage-based screen identifies antibacterial compounds selective for intracellular Salmonella Typhimurium.
Ellis MJ; Tsai CN; Johnson JW; French S; Elhenawy W; Porwollik S; Andrews-Polymenis H; McClelland M; Magolan J; Coombes BK; Brown ED
Nat Commun; 2019 Jan; 10(1):197. PubMed ID: 30643129
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of the latest fluoroquinolones against experimental Yersinia pestis.
Steward J; Lever MS; Russell P; Beedham RJ; Stagg AJ; Taylor RR; Brooks TJ
Int J Antimicrob Agents; 2004 Dec; 24(6):609-12. PubMed ID: 15555886
[TBL] [Abstract][Full Text] [Related]
39. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens.
Ng KM; Ferreyra JA; Higginbottom SK; Lynch JB; Kashyap PC; Gopinath S; Naidu N; Choudhury B; Weimer BC; Monack DM; Sonnenburg JL
Nature; 2013 Oct; 502(7469):96-9. PubMed ID: 23995682
[TBL] [Abstract][Full Text] [Related]
40. Phage Therapy Potentiates Second-Line Antibiotic Treatment against Pneumonic Plague.
Vagima Y; Gur D; Aftalion M; Moses S; Levy Y; Makovitzki A; Holtzman T; Oren Z; Segula Y; Fatelevich E; Tidhar A; Zauberman A; Rotem S; Mamroud E; Steinberger-Levy I
Viruses; 2022 Mar; 14(4):. PubMed ID: 35458417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
